Conjugated monoclonal antibodies are being used to treat a variety of cancers: - Breast Cancer: HER2-positive breast cancer can be treated with ADCs like Trastuzumab emtansine. - Lymphomas: Radioimmunoconjugates like Ibritumomab tiuxetan are used for non-Hodgkin lymphoma. - Leukemias: Some leukemias can be treated with conjugated mAbs targeting specific antigens.
